- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
28 cm
- Umfang
-
S. 906 - 1059
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Literaturangaben
- Erschienen in
-
World journal of urology ; Vol. 33, Nr. 7
- Schlagwort
-
Prostatakrebs
Krebs
Onkologie
Hoden
Männliches Geschlechtsorgan
Hodensack
Prostata
- Ereignis
-
Veröffentlichung
- (wo)
-
Heidelberg
- (wer)
-
Springer
- (wann)
-
2015
- Beteiligte Personen und Organisationen
-
Poel, Henk van der
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Aufsatzsammlung
Beteiligte
- Poel, Henk van der
- Springer
Entstanden
- 2015
Ähnliche Objekte (12)
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance
High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. oncological outcomes after a median 15-year follow-up
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance
Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance
High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. oncological outcomes after a median 15-year follow-up
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance
Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy
Impact of "time-from-biopsy-to-prostatectomy" on adverse oncological results in patients with intermediate and high-risk prostate cancer
Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer
Long-term and pathological outcomes of low- and intermediate-risk prostate cancer after radical prostatectomy: implications for active surveillance
High-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer. oncological outcomes after a median 15-year follow-up
DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
Prostate cancer
No detrimental effect of a positive family history on postoperative upgrading and upstaging in men with low risk and favourable intermediate-risk prostate cancer: implications for active surveillance
Influence of biopsy gleason score on the risk of lymph node invasion in patients with intermediate-risk prostate cancer undergoing radical prostatectomy